ImpediMed Ltd (IPD.AX) reported Loss for first half of -A$12.282 million
The company's bottom line came in at -A$12.282 million, or -A$0.006 per share. This compares with -A$11.146 million, or -A$0.006 per share, last year.
The company's revenue for the period rose 25.1% to A$7.516 million from A$6.008 million last year.
ImpediMed Ltd earnings at a glance (GAAP) :
-Earnings: -A$12.282 Mln. vs. -A$11.146 Mln. last year.-EPS: -A$0.006 vs. -A$0.006 last year.-Revenue: A$7.516 Mln vs. A$6.008 Mln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.